April 27, 2021
Malaria is caused by Plasmodium parasites. Among 5 parasite species, Plasmodium (P.) falciparum and P. vivax are the most widespread. They are transmitted to people through the bites of infected female Anopheles mosquitoes.
According to the World Health Organization (WHO), nearly half of the world’s population was at risk of malaria in 2019. P. falciparum parasites are responsible for most estimated malaria cases in the WHO African region, and P. vivax parasites in the WHO Region of the Americas.
Sanofi has produced several antimalarial drugs against P. falciparum and P. vivax parasites for about 70 years. In addition, Sanofi has developed malaria awareness program for school-age children who may suffer from malaria-induced anemia with an impact on their school attendance and cognitive development. These educational tools help children to find all the proliferation sites of mosquito in their environment and how to clear them away. Children can also learn about all malaria clinical symptoms and the actions to take in case of illness. Educating the adults of tomorrow should impact on their health behaviors and consequently that of the next generations.
Synergy Pharm is proud of providing medical writing support to Sanofi in various types of malaria projects over several years.